MedPath

Comparison Between Prepectoral and Subpectoral Breast Reconstruction

Recruiting
Conditions
Stage II Breast Cancer
Stage I Breast Cancer
Interventions
Procedure: The breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomy
Registration Number
NCT05833659
Lead Sponsor
Beijing Friendship Hospital
Brief Summary

There are controversies about breast implant-based reconstruction techniques. Our center pioneered single-port insufflation endoscopic nipple-sparing mastectomy (SIE-NSM) combined with stage I prosthesis reconstruction. The study's primary objective is to compare single-port endoscopic NSM combined with pre-pectoral breast reconstruction to the subpectoral breast reconstruction group regarding breast satisfaction.

This study is an ambispective cohort study. The study will be conducted at Beijing Friendship Hospital, affiliated with Capital Medical University. Patients will be enrolled retrospectively from January 2014 to March 2022 by reviewing the medical records and recruited prospectively from March 2022 to March 2025. The two cohorts are the pre-pectoral breast reconstruction cohort and the subpectoral breast reconstruction cohort, both following single-port insufflation endoscopic nipple-sparing mastectomy. The primary outcome of this study is postoperative breast satisfaction, which the BREAST-Q score will measure. The different variables will be compared using the Χ2 test for categorical variables and the Mann-Whitney test for continuous variables.

Detailed Description

Sample size and statistical analysis This study is an ambispective cohort study. According to the previous retrospective research data of the center, the breast satisfaction score is the main research object. The standard deviation was 2.6, the non-inferiority margin was 0.15, the test level was α=0.05, β=0.2, and a one-sided test was performed. Eighty patients will be needed for two cohorts in a 1:1 ratio. Considering the 10% loss to follow-up rate, 44 patients will be required to be enrolled in each group.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
88
Inclusion Criteria
  1. Female patients with preoperative pathologically confirmed early-stage invasive breast cancer (stage I or stage II) by core needle biopsy.
  2. Breast-conserving surgery is not possible due to the presence of contraindications to breast-conserving surgery, or the patient actively requests total mastectomy.
  3. Patients having willingness for breast reconstruction.
  4. Age between 18 to 70 years.
  5. Maximum diameter of the cancer lesion ≤ 3 cm.
  6. Physical examination and breast magnetic resonance imaging (MRI) confirmed that the tumor did not invade the skin, subcutaneous tissue, or chest wall.
  7. The distance between the lesion and the nipple is ≥2 cm, and it is confirmed by physical examination and MRI that the nipple-areola complex is not invaded.
  8. Eastern Cooperative Oncology Group (ECOG) Performance Status Scale of 0 to 2.
Exclusion Criteria
  1. patients having serious medical diseases, including unstable angina pectoris, myocardial infarction, and cerebrovascular accident within 6 months.
  2. Having history of malignant tumor (s) within 5 years.
  3. Patients under immunosuppressive therapy for organ transplantation.
  4. Having continuous systemic steroid hormone therapy.
  5. Pregnant or lactating women.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
The subpectoral breast reconstructionThe breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomyThe patients received subpectoral breast reconstruction after single-port insufflation endoscopic nipple-sparing mastectomy
The prepectoral breast reconstructionThe breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomyThe patients received prepectoral breast reconstruction after single-port insufflation endoscopic nipple-sparing mastectomy
Primary Outcome Measures
NameTimeMethod
breast satisfaction12 months after operation

measured by BREAST-Q score

Secondary Outcome Measures
NameTimeMethod
Animation deformity12 months after operation

confirmed by the doctor's physical examination

Adverse eventswithin 30 days after surgery

according to Clavien-Dindo system

Physical well-being of chest12 months after operation

measured by BREAST-Q score

Local recurrence and distant metastasis of breast cancer12 months after operation

physical examination or imaging examination with histologically confirmed

Trial Locations

Locations (1)

Beijing Friendship Hospital, Capital medical University

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath